Teriparatide Acetate

Picture of Teriparatide Acetate

Teriparatide Acetate

L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-α-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-α-glutamyl-L-arginyl-L-valyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-valyl-L-histidyl-L-asparaginyl-, acetate (1:1)

165967-81-7

Under Development

Lab Sample Available

Product Details

Teriparatide Acetate (CAS 165967-81-7) is a recombinant human parathyroid hormone 1–34 fragment (rhPTH[1-34]). The sequence of its 34 amino acids is Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe. The FDA has approved this drug for osteoporosis in postmenopausal women and men who are at high risk of breaking bones, as well as for osteoporosis caused by glucocorticoids. Teriparatide is the only anabolic (bone-forming) drug that is approved for osteoporosis. It activates PTH1R in osteoblasts, which encourages bone formation over resorption when taken once a day (20 µg SC, 20 µg/dose prefilled pen). 


ApiSyn sells Teriparatide Acetate as a pharmaceutical-grade reference standard for checking the quality of PTH peptides, validating HPLC methods, and studying oxidative degradation.

Chemical Name L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-α-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-α-glutamyl-L-arginyl-L-valyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-valyl-L-histidyl-L-asparaginyl-, acetate (1:1)
Molecular Formula C181H291N55O51S2 : C2H4O2
Molecular Weight 4117.8 : 60.1
CAS Number 165967-81-7